12A - The Michigan Daily - Thursday, March 14, 2002
Blue resumes Big Ten grind
against Badgers and Gophers
By Brian Schick
Daily Sports Writer
The Michigan women's tennis team enjoyed
its spring break a week later than the rest of the
student body - a break from tough competi-
tion at least.
The Wolverines (0-2 Big Ten, 4-5 overall)
return to action this weekend at the Varsity Tennis
Center against Big Ten foes Wisconsin and Min-
nesota. Michigan had taken a break from compe-
tition last weekend after its meet in Tampa, Fla.
against Southern Florida on March 2.
Michigan's 7-0 win against the Bulls in
Tampa was the first outdoor meet of the season,
and the team enjoyed the fun in the sun. While
the weather in Ann Arbor wasn't horrible,
Michigan coach Bisty Ritt described the gor-
geous weather in Tampa simply as "79 degrees
and very windy." The venue proved to be a test
for the team, as Michigan has not played out-
doors the entire season.
It was also a break from the Big Ten, which
hasn't treated the Wolverines too kindly this
season. So far, Michigan lost to the top two fin-
ishers from last year (Northwestern and Illi-
"It was nice to get a break from the Big Ten,"
Ritt said of her time in Florida. "It was helpful
(for us) to hit a lot of balls outside and get used
to the heat and the wind. The team played well
at all positions."
Ritt used the break to hold several tough prac-
tices in preparation for Wisconsin (3-0, 8-3) on
Saturday and Minnesota (0-3, 4-9) on Sunday.
"It was a long trip," Ritt said of the team's
first road trip. "I think we needed days to rest
and recover, but especially regroup and refocus
on with what we did well on the trip and what
we need to work on"
Ritt indicated that the break came along at
just the right time, as she felt the Wolverines
VARSITY TENNIS CENTER
Who: Michigan (0-2 Big Ten, 4-5 overall) vs. Wisconsin
(3-0, 8-3) and Minnesota (0-3, 4-9)
When: 11 a.m. Saturday and Sunday
Latest: A healthy and rested Michigan team has an
excellent chance of earning its first Big Ten victory
of the season against the struggling Golden Gophers.
needed to readjust to Ann Arbor and get back
into their typical daily schedule of classes and
She felt that both players and coaches were
happy for the break and didn't think it hurt any
momentum from the win against South Florida.
The time off this week also gave the Wolver-
ines an extended chance to examine the Bad-
gers, one of just two teams that is still
undefeated in the Big Ten (Northwestern being
the other). One of Michigan's two victories in
the Big Ten last year came against Wisconsin.
Minnesota is at the other end of the spectrum
in terms of success in the Big Ten. The Gophers
are a team that has yet to win in the conference
thus far, and they haven't had much success out-
side the Big Ten either. Minnesota lost to
DePaul 5-2 on Feb. 15, while Michigan
trounced the Blue Demons 6-1 in January.
Michigan golfers stymied by harsh winter a
Sophomore defenseman Mike Komisarek Is one of the Wolverines' biggest hitters and was rewarded
with a first-team All-CCHA selection.
By Gennaro Filice
For The Daily
Continued from Page 8A
three minutes Friday night, to be exact. The
three-game series format of the first round
allowed them to recover from the loss, but this
is a luxury they no longer have.
Michigan's defense must continue to limit
the number of shots goalie Josh Blackburn
faces. But it also needs to focus on preventing
any and all breakdowns from occurring.
"When it comes to playoff time, defense
wins or loses games for you," Burnes said.
"They're usually one-goal games and it's all
defense. You have to let your defense create
offense, and go from there."
SEE YOU LATER, BUDDY: Bowling Green
Athletic Director Paul Krebs announced yes-
terday that coach Buddy Powers, who just
completed his eighth year at Bowling Green,
will not return next season. He held an all-
time record of 135-149-26 at Bowling
The Falcons were hoping to do a little more
damage in the CCHA this season after last
year's conference tournament run. Last year,
the ninth-seeded Falcons swept second-seeded
Miami and defeated Northern Michigan in the
play-in game before falling to Michigan State
in the semifinals, 2-1.
But the Falcons (7-18-3 CCHA, 9-25-6 over-
all) couldn't cut it, as they finished 11th in the
CCHA and were swept by Michigan State in
the first round of this year's tournament.
The Michigan women's golf team's biggest
foe isn't the opposition. It isn't the course
either. The Wolverines' toughest opponent isn't
even what many golfers refer to as their great-
est enemy - themselves. The main adversary
of Michigan golfers this spring was none other
than the Michigan winter. Although the winter
has been mild around the Midwest, it has still
wreaked havoc on the Wolverines' practice
"We haven't been able to play a course in
four months," Michigan coach Kathy Teichert
The Wolverines finished their fall season
with a perfect 4-0 campaign, but they have
sputtered this spring, finishing fourth in their
first two tournaments.
"I can't expect the same results as they had in
the fall because there is just no course around
us to play on," Teichert said.
Michigan looks forward to hitting the links,
and hopefully improving its record, at the
upcoming- Hatter Spring Fling in Daytona, Fla.
The tournament, which takes place Saturday
and Sunday, will be the Wolverines' second trip
to Florida in three weeks (Michigan last played
in Bradenton, Fla. in the Midwest Classic).
At the Midwest Classic, "I think we had a
good second go-around for the spring. Our
short game was a lot better," Teichert said. "Our
goal in the Hatter Spring Fling is obviously to
win and have some high performers."
Teichert will keep the same lineup this week-
end that she has played all year: Junior Kim
Benedict, senior Misia Lemanski, freshman
Laura Olin, senior Cortney Reno and senior
. Much of the team's early success this season
is due to the steady play of Benedict. Not only
does Benedict lead Michigan in scoring with a
74.94 average (which places her 79th in the
Golfweek/Sagarin individual rankings), but she
has also been the team's low scorer in four of
"Kim leads by example, and she's a very
What: The Hatter Spring Fling
When: 8:40 a.m. Saturday, 8 a.m. Sunday
Latest: Freshman Laura Olin has been a solid performer
for Michigan, finishing in the top 15 in four different tour-
naments this year.
hard worker," Teichert said. "She is also a very
Another solid performer for Michigan has
been Olin. Just a freshman, Olin has been a
pleasant surprise for the Wolverines. She has
played in all six tournaments this season, and her
consistency shows in her four top-15 finishes. In
the final day of the Midwest Classic, Olin record-
ed a brilliant final round 72, earning her a tie for
fourth place - Michigan's best individal finish.
"I knew that she would be a good player for
us," Teichert said. "I though it would take a lit-
tle more time for her to develop, but she has
shown a lot of ambition towards her game. She
wants to play, but not only play, she wants to be
a top scorer for the team."
Continued from Page 8A
collegiate one. The French have more
time to rest in between their meets than
the Wolverines, and they don't have to
worry about going to class like Michi-
"They get a lot more long breaks in
between competition where they can
really focus on learning a new skill or
something along that line," Golder
In late October, the French took
fourth at the 2001 Artistic Gymnas-
tics Championships in Belgium
behind a strong performance from
Francois Ruffier, and the French
Come to the Dell table in front of
Ulrich's Bookstore on March 14
to pick up a free T-shirt. Get spotted
with the T-Shirt on Friday, March 15
and get a chance to win a FREE
Dell Inspiron Notehookl!I
Undergrads + Graduate Students
" Engage in provocative summer study with Stanford faculty
* Live on campus - just minutes from West Coast beaches
* Develop friendships with students from around the world
" Earn full-year credit in foreign languages and physics
* New 3-week Institutes in Creative Writing & International Security
Courses offered in: Psychology, Philosophy, Economics,
Computer Science, Biology, Engineering, History, Political
Science, Music, Drama, Classics, Chemistry, Athletics, Art &
Art History, Mathematics, and English for Foreign Students
Stanford University Summer Session
Building 590, Room 103 *"Stanford, CA 94305-3005
Ph: (650)>723-3109 - Fax: (650) 725-6080 * Email: firstname.lastname@example.org
T-shirts will be available on a first come
first serve basis starting at 9 A.M.
More detail will be available
at the Dell table on March14.
inspire Isystem will be
shipped to the winner approximately
four weeks after the event.
should be especially focused tomor-
row, with the European Champi-
onships quickly approaching.
For Michigan, there is something
special about facing a team from across
the ocean. Golder says he has seen
some additional intensity from his team
over practice the last few weeks.
"It's probably on their minds out-
side of the gym more than just a reg-
ular dual meet against a team like
Illinois or Penn State," Golder said.
"Not to trivialize a meet like that,
those are important too, but this just
brings a special focus."
Continued from Page SA
Associate head coach Angela Jack-
son filled in for Sue Guevara while,
the head coach attended to her ill
mother. As the head coach for a day,
Jackson got a taste of the frustration
Guevara has felt all season.
"We just couldn't get it going
offensively," Jackson said. "We
scored a bunch of points (at the Big
Ten Tournament). I thought we played
very well there and thought we could
build on that. It just didn't happen for
The reason was Valparaiso's
swarming defense, which Crusaders'
coach Keith Freeman compared to the
Wisconsin men's basketball team
under Dick Bennett that went to the
Final Four in 2000.
"The way we play defense, if you
aren't used to it, it's different," Jack-
son said. "It is the old Dick Bennett
stuff. We are contesting every pass."
Valparaiso's improved rebounding
in the second half was also crucial in
the victory. After being outrebounded
by nine in the first half, the Crusaders
had 21 boards in the second stanza,
including one that set up Valparaiso's
key four-point possession.
The Crusaders jumped out to a 30-
18 edge, led by Nieuwveen's 18
points. As a team, Wlparaiso shot 59
percent from inside the 3-point arc.
Smith was the only Michigan player
to record double digits in the first
half, tallying 12 points.
The Wolverines trailed the entire
game but closed the deficit to just
one point four minutes into the sec-
ond half after a 9-2 run coming out of
FG FT REB
MIN M-A M-A 0-T A F PTS
Schober 36 6-11 0-3 0-4 1 2 13
Gray 39 4-14 0-1 1-8 4 1 9
Nieuwveen 30 9-9 8-8 1-7 1 3 26
Boone 39 5-11 3-4 8-12 6 3 14
Knoester 37 0-6 0-0 0-2 2 3 0
McIntosh 2 0-0 0-0 0-0 0 0 0
Strangler 8 0-1 0-0 0-0 0 0 0
Springer 3 0-1 0-0 0-0 0 0 0
Frede 6 0-1 0-0 0-1 0 1 0
Totals 200 24-54 11-1610-3514 13 62
FG%: .444. FT%: .688. 3-point FG: 3-16, .188
(Schober 1-2, Boone 1-3, Gray 1-5, Springer 0-1, .
Knoester 0-5) Blocks: 3 (Knoester 2, Springer).
Steals: 9 (Nieuwveen 4, Knoester 2, Gray, Schober,
Springer). Turnovers: 14 (Boone 4, Schober 4,
Gray, Knoester, McIntosh, Nieuwveen). Technical
Cont race tive In ect ion
medroxyprogesterone acetate injectable suspension
3irtk con~trol yJou -thindk afEou-t ju~st '+1- a year
DEPO-PROVERA* Contraceptive Injection
(medroxyprogesterone acetate injectable suspension, USP)
This product is intended to prevent pregnancy. It does not protect against HIV
Infection (AIDS) and other sexually transmitted diseases.
What Is DEPO-PROVERA contraceptive Injection?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an
intramuscular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To
continue your contraceptive protection, you must return for your next injection promptly at the
end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a
chemical similar to (but not the same as) the natural hormone progesterone, which is produced
by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by
preventing your egg cells from ripening. If an egg is not released from the ovanes during your
menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA
also causes changes in the lining of your uterus that make it less likely for pregnancy to occur.
How effective is DEPO-PROVERA Contraceptive Injection?
The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the
recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROVERA
Contraceptive Injection?"). To make sure you are not pregnant when you first get
DEPO-PROVERA Contraceptive Injection, your first inection must be given ONLY during
the first 5 days of a normal menstrual period; ONLY within the first 5 days after childbirth if not
breast-feeding; and, if exclusively breast-feeding ONLY at the sixth week after childbirth. It is a
long-term injectable contraceptive when administered at 3-month (13-week) intervals.
DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable
methods of birth control available. This means that the average annual pregnancy rate is less than
one for every 1 00 women who use DEPO-PROVERA. The effectiveness of most contraceptive
methods depends in pat on how reliably each woman uses the method. The effectiveness of
DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other
contraceptive methods and give you the information you need in order to decide which
contraceptive method is the right choice for you.
The following table shows the percent of women who got pregnant while usin different kinds of
contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected
in women who use each method exactly as it should be used) and the typical rate of pregnancy
(which includes women who became pregnant because they forgot to use their birth control or
because they'did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use
if you have had cancer of the breast
"if you have had a stroke
i f you have or have had blood clots (phlebitis) in your legs
" if you have problems with your liver or liver disease
" if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other
What other things should I consider before using DEPO-PROVERA
You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is
important to tell your health-care provider if you have any of the following:
" a family history of breast cancer
- an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or
bleeding from your nipples
" kidney disease
- irregular or scanty menstrual periods
- high blood pressure
" epilepsy (convulsions or seizures)
- diabetes or a family history of diabetes
" a history of depression
* if you are taking any prescription or over-the-counter medications
This product is intended to prevent pregnancy. It does not protect against
transmission of HIV (AIDS) and other sexually transmitted diseases such as
chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
What if I want to become pregnant after using DEPO-PROVERA Contraceptive
Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last
injection for its effect to wear off. Based on the results from a large study done in the United States,
for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that
about half of those who become pregnant will do so in about 10 months after their last injection;
about two thirds of those who become pregnant will do so in about 12 months; about 83% of
those who become pregnant will do so in about I5 months; and about 93% of those who become
prenant will do so in about 18 months after their last injection. The length of time you use
EPO-PROVERA has no effect on how long it takes ou to become pregnant after you stop using it
What are the risks of using DEPO-PROVERA Contraceptive Injection?
I irregular Menstrual Bleeding
The side effect reported most frequently by women who use DEPO-PROVERA for
contraception is a change in their normal menstrual cycle. During the first year of using
DEPO-PROVERA, you might have one or more of the following changes: irregular or
unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding
at all. Unusually heavy or continuous bleeding, however; is not a usual effect of DEPO-PROVERA;
and if this hap pens, you Should see your health-care provider right away. With continued use of
DEPO-PROVE d bleeding usually decreases, and many women stop having periods completely
In clinical studies of DEPO-PROVERA. 55% of the women studied reported no menstrual
bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual
bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA
Women who use hormone-based contraceptives may have an increased risk of blood clots or
stroke. Also, ifa contraceptive method fails, there is a possibility that the fertilized egg will begin
to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should
tell your health-care provider if you have any of the problems listed in the next section,
What symptoms may signal problems while using DEPO-PROVERA
Call your health-care provider immediately if any of these problems occur following an injection
" sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot
in the lung)
- sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or
speech, weakness, or numbness in an arm or leg (indicating a possible stroke)
- severe pain or swelling in the calf (indicating a possible clot in the leg)
" unusually heavy vaginal bleeding
- severe pain or tendernessin the lower abdominal area
p4ersistent pain. pus. or bleeding at the injection site
e t e possible side effects of DEPO-PROVERA Contraceptive Injection?
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of
the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds
during the first year of use. You may continue to gain weight after the first year. Women in one
large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over
those ? years, or approximately 4 pounds per year. Women who continued for 4 years gained an
average total of 13.8 pounds over those 4 years, or approximately 3.5 pounds per year. Women
who continued for 6 years gained an average total of I 6.5 pounds over those 6 years, or
approximately 2.75 pounds per year
2. Other Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects. that may or may not have been related to their use of
DEPO-PROVERA:.Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal
cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal.
discharge or irritation, breast swelling and tendemess, bloating, swelling of the hands or feet,
backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot
flashes, and joint pain. Other-problems were reported by very few of the women in the clinical
trials, but some of these could be serious. These include convulsions, jaundice, urinary tract
infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein
thrombosis, pulmonary embolus, breast cancer or cervical cancer. If these or any other problems
occur during your use of DEPO-PROVERA, discuss them with your health-care provider
Should any precautions be followed during use of DEPO-PROVERA
During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your
periods may stop completey. If you have been receiving your DEPO-PROVERA injections
regularly every 3 months (13 weeks), then you are probably not pregnant. However if you think
that you may be pregnant, see your health-care provider
21aboratory Test Interactions
If ou are scheduled for any laboratory tests, tell your health-care provider that you are using
Method Expected wypical
DEPO-PROVERA 0.3 03
Implants (Norplant) 02* 0.2*
temale sterilization 0.2 0.4